A comparison of the effects of melengestrol acetate with a combination of hydrocortisone acetate and medroxyprogesterone acetate and with other steroids in the treatment of experimental alleric encephalomyelitis in Wistar rats.
D000818:Animals; D001921:Brain / Q000473:pathology; D004338:Drug Combinations; D004357:Drug Synergism; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy* / Q000473:pathology; D004958:Estradiol / Q000627:therapeutic use; D004964:Estriol / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D006854:Hydrocortisone / Q000627:therapeutic use*; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D008552:Melengestrol Acetate / Q000627:therapeutic use; D008656:Mestranol / Q000627:therapeutic use; D009277:Nandrolone / Q000627:therapeutic use; D011245:Pregnadienes / Q000627:therapeutic use*; D051381:Rats; D013116:Spinal Cord / Q000473:pathology; D013739:Testosterone / Q000627:therapeutic use
D004338:Drug Combinations; D011245:Pregnadienes; D013739:Testosterone; D004997:Ethinyl Estradiol; D004958:Estradiol; D008552:Melengestrol Acetate; D009277:Nandrolone; D008656:Mestranol; D004964:Estriol; D008525:Medroxyprogesterone; D006854:Hydrocortisone